← ANALYST RATINGS · TIPRANKS
Astrana Health (ASTH): analyst forecast and price target
Analyst consensus
Strong Buy7 Buy1 Hold0 Sell
Ratings of 8 analysts in the last 3 months12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $52.40, the highest $65.00, the lowest $41.00. The average is +42.4% from the last price of $36.81.
Analyst ratings 12
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI DeepSeek Medical - Care FacilitiesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $40.00 → $41.00+2.5% | Hold | +11.4% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI Google Medical - Care FacilitiesGemini 3.1Pro | TipRanks - Google | $42.00 → $41.00−2.4% | Hold | +11.4% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI PerPlexity Medical - Care FacilitiesPerPlexity SonarPro | TipRanks - PerPlexity | $41.00 → $40.00−2.4% | Hold | +8.7% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI xAi Medical - Care FacilitiesxAI Grok-4 | TipRanks - xAI | $36.00 → $41.00+13.9% | Hold | +11.4% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI OpenAI Medical - Care FacilitiesOpenAI 5.2 | TipRanks - OpenAI | $36.00 → $41.00+13.9% | Hold | +11.4% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI Anthropic Medical - Care FacilitiesAnthropic Opus-4.6 | TipRanks - Anthropic | $36.00 → $39.00+8.3% | Hold | +5.9% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $53.00 | Buy | +44.0% | Reiterated | 07.10.26on TipRanks 04:00 | +0.6%next day −3.0% · 5 days +2.5% | ↗ |
| Eugene Mannheimer★★★★★★★★★★#3417 · hits 51% · avg +6.8% | Freedom Capital Markets | $50.00 | Buy | +35.8% | Reiterated | 01.10.26on TipRanks 11:50 | −2.0%next day +2.0% · 5 days +1.4% | ↗ |
| Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% | Truist Financial | — | Buy | — | Reiterated | 29.09.26on TipRanks 08:11 | +1.1%next day +0.5% · 5 days +2.4% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $53.00 | Buy | +44.0% | Initiated | 15.09.26on TipRanks 06:40 | −2.7%next day −1.3% · 5 days −10.8% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $65.00 | Buy | +76.6% | Reiterated | 09.08.26on TipRanks Aug 10 05:30 | +4.8%next day −7.7% · 5 days +6.1% | ↗ |
| Matthew Shea★★★★★★★★★★#6280 · hits 52% · avg +3.4% | Needham | $41.00 | Buy | +11.4% | Reiterated | 07.08.26on TipRanks 07:45 | +4.2%next day +4.8% · 5 days +13.7% | ↗ |
| Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% | KeyBanc | — | Hold | — | Reiterated | 07.08.26on TipRanks 06:25 | +4.2%next day +4.8% · 5 days +13.7% | ↗ |
| Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% | William Blair | — | Buy | — | Reiterated | 06.08.26on TipRanks 20:55 | +4.2%next day +4.8% · 5 days +13.7% | ↗ |
| Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% | TD Cowen | $50.00 | Buy | +35.8% | Assigned | 14.07.26on TipRanks 06:10 | +2.5%next day −4.4% · 5 days −6.8% | ↗ |
| Jack Slevin★★★★★★★★★★#2268 · hits 61% · avg +22.1% | Jefferies | $53.00 | Buy | +44.0% | Reiterated | 30.06.26on TipRanks 08:45 | +2.3%next day +7.5% · 5 days −0.1% | ↗ |
| Michael Craig Jones★★★★★★★★★★#11984 · hits 45% · avg −19.2% | Bank of America Securities | — | Buy | — | Reiterated | 13.05.26on TipRanks 10:55 | +1.4%next day −2.3% · 5 days −2.4% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $40.00 → $45.00+12.5% | Buy | +22.2% | Reiterated | 08.05.26on TipRanks 08:50 | +8.1%next day −3.6% · 5 days −2.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Astrana Health
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $52.00 at a price of $35.57 (+46.2%); now: $52.40 at $36.81 (+42.4%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 2 | 2 | 2 |
| Buy | 17 | 16 | 16 | 11 | 10 | 9 |
| Hold | 3 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.46 (from $0.35 to $0.54). Last quarter: $0.40.
Sales
Next quarter’s sales estimate — $1.0B (from $1.0B to $1.0B). Last quarter: $973M.
Best top-analyst consensus in the sector · Healthcare
About Astrana Health
- CEO: Brandon K. Sim
- Employees: 3,000
- 1668 S. Garfield Avenue, Alhambra, CA, 91801, US
- www.astranahealth.com
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
Data from the stock’s TipRanks forecast page, read 47 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗